These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 17396695)
1. Intraocular biodistribution of mono-L-aspartyl chlorin e6 in a primate choroidal neovascularization model. Mori K; Kanai K; Peyman GA; Yoneya S Ophthalmic Surg Lasers Imaging; 2007; 38(2):142-7. PubMed ID: 17396695 [TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6. Mori K; Yoneya S; Anzail K; Kabasawa S; Sodeyama T; Peyman GA; Moshfeghi DM Retina; 2001; 21(5):499-508. PubMed ID: 11642380 [TBL] [Abstract][Full Text] [Related]
3. Dynamic observation of selective accumulation of a photosensitizer and its photodynamic effects in rat experimental choroidal neovascularization. Hikichi T; Mori F; Nakajima S; Takamiya TA; Takeda M; Sasaki M; Horikawa Y; Yoshida A Retina; 2001; 21(2):126-31. PubMed ID: 11321138 [TBL] [Abstract][Full Text] [Related]
4. [Potential of photodynamic therapy with a second-generation sensitizer: mono-L-aspartyl chlorin e6]. Mori K; Ohta M; Sano A; Yoneya S; Sonoda M; Kaneda A; Sato Y Nippon Ganka Gakkai Zasshi; 1997 Feb; 101(2):134-40. PubMed ID: 9124093 [TBL] [Abstract][Full Text] [Related]
5. Fluorescence properties of a hydrophilic sensitizer in pigmented rats, rabbits, and monkeys. Moshfeghi D; Peyman GA; Kazi AA; Unal M; Khoobehi B; Yoneya S; Mori K Ophthalmic Surg Lasers; 1999; 30(9):750-3. PubMed ID: 10574497 [TBL] [Abstract][Full Text] [Related]
6. Pilot study of topical delivery of mono-L-aspartyl chlorin e6 (NPe6): implication of topical NPe6-photodynamic therapy. Wong TW; Aizawa K; Sheyhedin I; Wushur C; Kato H J Pharmacol Sci; 2003 Oct; 93(2):136-42. PubMed ID: 14578580 [TBL] [Abstract][Full Text] [Related]
7. In vivo imaging of a new indocyanine green micelle formulation in an animal model of laser-induced choroidal neovascularization. Meyer J; Cunea A; Sonntag-Bensch D; Welker P; Licha K; Holz FG; Schmitz-Valckenberg S Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6204-12. PubMed ID: 25190666 [TBL] [Abstract][Full Text] [Related]
8. Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6). Mori K; Yoneya S; Ohta M; Sano A; Anzai K; Peyman GA; Moshfeghi DM Ophthalmology; 1999 Jul; 106(7):1384-91. PubMed ID: 10406627 [TBL] [Abstract][Full Text] [Related]
9. Retreatment effect of NPe6 photodynamic therapy on the normal primate macula. Nakashizuka T; Mori K; Hayashi N; Anzail K; Kanail K; Yoneya S; Moshfeghi DM; Peyman GA Retina; 2001; 21(5):493-8. PubMed ID: 11642379 [TBL] [Abstract][Full Text] [Related]
10. Localization of experimental submucosal esophageal tumor in rabbits by using mono-L-aspartyl chlorin e6 and long-wavelength photodynamic excitation. Sheyhedin I; Okunaka T; Kato H; Yamamoto Y; Sakaniwa N; Konaka C; Aizawa K Lasers Surg Med; 2000; 26(1):83-9. PubMed ID: 10637007 [TBL] [Abstract][Full Text] [Related]
11. PDT to monkey CNV with ATX-S10(Na): inappropriateness of early laser irradiation for selective occlusion. Obana A; Gohto Y; Kaneda K; Nakajima S; Miki T Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2639-45. PubMed ID: 11581211 [TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy of intestinal tumors with mono-L-aspartyl chlorin e6 (NPe6): a basic study. Kikuchi T; Asakura T; Aihara H; Shiraki M; Takagi S; Kinouchi Y; Aizawa K; Shimosegawa T Anticancer Res; 2003; 23(6C):4897-900. PubMed ID: 14981942 [TBL] [Abstract][Full Text] [Related]
13. Localization of rose bengal, aluminum phthalocyanine tetrasulfonate, and chlorin e6 in the rabbit eye. Haimovici R; Ciulla TA; Miller JW; Hasan T; Flotte TJ; Kenney AG; Schomacker KT; Gragoudas ES Retina; 2002 Feb; 22(1):65-74. PubMed ID: 11884881 [TBL] [Abstract][Full Text] [Related]
14. [A new approach for studying the retinal and choroidal circulation]. Yoneya S Nippon Ganka Gakkai Zasshi; 2004 Dec; 108(12):836-61; discussion 862. PubMed ID: 15656089 [TBL] [Abstract][Full Text] [Related]
15. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model. Ferrario A; Kessel D; Gomer CJ Cancer Res; 1992 May; 52(10):2890-3. PubMed ID: 1581904 [TBL] [Abstract][Full Text] [Related]
16. Histologic localization of indocyanine green dye in aging primate and human ocular tissues with clinical angiographic correlation. Chang AA; Morse LS; Handa JT; Morales RB; Tucker R; Hjelmeland L; Yannuzzi LA Ophthalmology; 1998 Jun; 105(6):1060-8. PubMed ID: 9627657 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces. Chan AL; Juarez M; Allen R; Volz W; Albertson T Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):72-8. PubMed ID: 15752124 [TBL] [Abstract][Full Text] [Related]
18. Selective photodynamic effects of the new photosensitizer ATX-S10(Na) on choroidal neovascularization in monkeys. Obana A; Gohto Y; Kanai M; Nakajima S; Kaneda K; Miki T Arch Ophthalmol; 2000 May; 118(5):650-8. PubMed ID: 10815157 [TBL] [Abstract][Full Text] [Related]
19. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model. Gomer CJ; Ferrario A Cancer Res; 1990 Jul; 50(13):3985-90. PubMed ID: 2354446 [TBL] [Abstract][Full Text] [Related]
20. Threshold power levels for NPe6 photodynamic therapy. Kazi AA; Peyman GA; Unal M; Khoobehi B; Yoneya S; Mori K; Moshfeghi D; Moshfeghi AA Ophthalmic Surg Lasers; 2000; 31(2):136-42. PubMed ID: 10743925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]